Bond Biosciences

Parkville, MO · Founded 2015 · Privately Held (backing)

Developer of small molecule-based therapeutics designed to prevent and treat ion-related human diseases. Bond Biosciences is based in Parkville, MO and was founded in 2015. Its last reported valuation was $122 million in Jan 2022. It has raised $17.1 million across 2 recorded rounds; the latest was a $5.9 million early-stage round in Apr 2026.

Last reported valuation
$121.8M
Oct 2026
Priced at
—
Total raised
$17.1M
Last round
Early Stage VC
Apr 2026
What is Bond Biosciences worth?
$121.8Mlast reported valuation · Oct 2026

Bond Biosciences's last reported valuation, Jan 2022. Nothing priced has surfaced since.

Free account
More of Bond Biosciences with a free account
  • ·Watch Bond Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Bond Biosciences funding history

2 rounds
DateRoundRaisedPost-money
Apr 2026Early Stage VC$5.9M▮
Aug 2024Seed Round$4.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Bond Biosciences valuation

Bond Biosciences's last reported valuation was $122 million in Jan 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Bond Biosciences raised?

Bond Biosciences has raised $17.1 million in total; 2 of its rounds are on record. The largest on record was a $5.9 million early-stage round in Apr 2026.

Bond Biosciences has filed 4 Form Ds with the SEC since 2024, most recently in Jan 2026 ($4.5 million sold to 91 investors).

How Bond Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Bond Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Bond Biosciences

What is Bond Biosciences worth?
Bond Biosciences is valued at $121.8M as of Oct 2026. Bond Biosciences's last reported valuation, Jan 2022. Nothing priced has surfaced since.
How much has Bond Biosciences raised?
Bond Biosciences has raised $17.1M in total funding across 2 recorded rounds.
When did Bond Biosciences last raise?
Bond Biosciences last raised in Apr 2026 (Early Stage VC), raising $5.9M.